Neurocrine Bioscience buy Canaccord Genuity Group Inc.
Start price
30.03.23
/
50%
€89.90
Target price
30.03.24
€120.95
Performance (%)
47.22%
End price
01.04.24
€132.35
Summary
This prediction ended on 01.04.24 with a price of €132.35. The BUY prediction by Canaccord_Genuity_Gr for Neurocrine Bioscience saw massive gains of 47.22%. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | -2.750% | -2.750% | -15.158% |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at Canaccord Genuity Group Inc. from a "hold" rating to a "buy" rating. They now have a $132.00 price target on the stock, up previously from $124.00.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten